ElevateBio

What about the smaller players in the industry – and particularly those just starting out? Added by popular demand, this category highlights a budding new start up. To be eligible for inclusion, the company must have been formed no earlier than 2016.

ElevateBio was founded in 2017 by David Hallal, Vikas Sinha, and Mitchell Finer. The goal was to help drug companies accelerate their cell and gene therapies through technologies, such as gene editing, induced pluripotent stem cells, and cell, protein, and vector engineering. The company has formed a number of partnerships, including with Affini-T Therapeutics, the California Institute of Regenerative Medicine, the University of Pittsburgh, and Boston Children’s Hospital, with the company describing itself as an “ecosystem.”

In 2020, the company’s BaseCamp facility won an Award for operational excellence in the ISPE Facility of the Year Awards, with judges describing the facility as a “gamechanger for cell and gene therapy.”